# Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

> **NCT02335099** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Virginia** · enrollment: 54 (actual)

## Conditions studied

- End Stage Renal Disease
- Vascular Access Patency

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02335099
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2022-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335099, "Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02335099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*